Dr. Jörg Fabian

Current affiliations

Institute for Pharmaceutical and Medical Chemistry

0000-0001-9673-5527

Publications

Development and validation of a bioanalytical method for the quantification of methotrexate from serum and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS. Opitz P, Fobker M, Fabian J, Hempel G (2024) In: Journal of Chromatographic Science, 1715, 464610. Research article (journal)
Investigations on the metabolic stability of cytosolic phospholipase A 2α inhibitors with 1-indolylpropan-2-one structure Fabian J., Hanekamp W., Thomas M.H., Olivier J.L., Lehr M. (2013) In: Chemico-Biological Interactions, 206(2). Research article (journal)
Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E 2 synthase-1 Wiegard A., Hanekamp W., Griessbach K., Fabian J., Lehr M. (2012) In: European Journal of Medicinal Chemistry, 48(null). Research article (journal)
Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ1 receptor ligands Köhler J., Bergander K., Fabian J., Schepmann D., Wünsch B. (2012) In: Journal of Medicinal Chemistry, 55(20). Research article (journal)
1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity. Drews A, Bovens S, Roebrock K, Sunderkötter C, Reinhardt D, Schäfers M, van der Velde A, Schulze Elfringhoff A, Fabian J, Lehr M (2010) In: Journal of Medicinal Chemistry, 53(14). Research article (journal)

Show all publications

Projects

Personalized Mental Health Monitoring by Digital Phenotyping and Medication Analysis (PersonMe)

Duration: 15/07/2025 - 14/07/2028

Funded by: MWIKE NRW - EFRE/JTF-Programm - Innovationswettbewerb Gesünder.IN.NRW

Type of project: Individual project